Lymphoseek: Clinical Trials

10 trials of Lymphoseek, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 3 terminated, 1 recruiting, 1 withdrawn. 10 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 210Completed 5, Terminated 3, Recruiting 1, Withdrawn 1

Follow Lymphoseek: new trials by email Literature Review of Lymphoseek trials Research Report on Lymphoseek

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT Trial
Biospecimen Collection, Carboplatin, Cisplatin - Oral Cavity Squamous Cell Carcinoma, Stage I Lip and Oral Cavity Cancer AJCC v8
Phase 2RecruitingUniversity of Michigan Rogel Cancer Center502025-07-172026-07-31
Comparison of Tc 99m Tilmanocept Imaging With IHC Analysis of CD206 Expression in Synovial Tissue of Subjects With RA
Tc 99m tilmanocept - Rheumatoid Arthritis
Phase 2TerminatedNavidea Biopharmaceuticals202021-09-142025-01-08
Development of a Normative Database for Rheumatoid Arthritis (RA) Imaging With Tc99m Tilmanocept
Tc99m tilmanocept - Rheumatoid Arthritis
Phase 2CompletedNavidea Biopharmaceuticals1342021-05-272025-01-08
Concurrent Use Lymphoseek & Indocyanine Green in Sentinel Lymph Node Detection in Endometrial Cancer
Lymphoseek, Single Photon Emission Computed Tomography (SPECT), Indocyanine Green (ICG) - Endometrial Cancer
Phase 2TerminatedStanford University62021-01-202023-10-11
Panitumumab-IRDye800 Compared to Sentinel Node Biopsy and (Selective) Neck Dissection in Identifying Metastatic Lymph Nodes in Patients With Head&Neck Cancer
Panitumumab-IRDye800, Lymphoseek - Head and Neck Squamous Cell Carcinoma, Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Phase 2CompletedEben Rosenthal32019-08-012022-11-10
Evaluation of the Precision and Sensitivity of Tilmanocept Uptake Value (TUV) on Tc 99m Tilmanocept Planar Imaging
Tc 99m tilmanocept - Rheumatoid Arthritis
Phase 2CompletedNavidea Biopharmaceuticals1162019-04-082023-08-24
A Prospective, Open-Label, Multi-center Comparison of Lymphoseek Identified Lymph Nodes and Clinically Identified Lymph Nodes of Subjects With Known Cancer of the Anus
Lymphoseek - Anal Cancer
Phase 2WithdrawnCardinal Health 414, LLC2016-09-012017-03-15
A Trial of Comparing the Pathology Status of Lymphoseek®-Identified Sentinel Lymph Nodes Relative to the Pathological Pathology Status of Nonsentinel Lymph Nodes in Nodal Staging of Subjects With Known Cancer of the Cervix Who Are Undergoing Lymph Node Dissection
Tc99m tilmanocept - Uterine Cervical Neoplasms
Phase 2TerminatedCardinal Health 414, LLC182016-01-012019-02-11
A Study of Lymphoseek® as a Lymphoid Tissue Targeting Agent in Pediatric Patients With Melanoma, Rhabdomyosarcoma, or Other Solid Tumors Who Are Undergoing Lymph Node Mapping
Tc99m tilmanocept, Vital Blue Dye (optional), Lymph Node Mapping - Rhabdomyosarcoma, Melanoma
Phase 2CompletedCardinal Health 414, LLC242015-08-012024-06-28
Evaluation of Tc 99m Tilmanocept Localization in Primary Cutaneous Kaposi's Sarcoma and Lymphatic Drainage by SPECT/CT
Tc 99m tilmanocept - Kaposi's Sarcoma
Phase 2CompletedNavidea Biopharmaceuticals52014-09-012016-09-27

Conditions studied

Arthritis, Rheumatoid (3)  ·  Squamous Cell Carcinoma of Head and Neck (2)  ·  Anus Neoplasms (1)  ·  Disease (1)  ·  Endometrial Neoplasms (1)  ·  Head and Neck Neoplasms (1)  ·  Melanoma (1)  ·  Mouth Neoplasms (1)  ·  Rhabdomyosarcoma (1)  ·  Sarcoma, Kaposi (1)  ·  Uterine Cervical Neoplasms (1)

Sponsors

Navidea Biopharmaceuticals (4)  ·  Cardinal Health 414, LLC (3)  ·  Eben Rosenthal (1)  ·  Stanford University (1)  ·  University of Michigan Rogel Cancer Center (1)

Countries

United States (9)  ·  United Kingdom (1)

Top investigators

Michael Blue, MD (6)  ·  Amer K Karam, MD (1)  ·  Bonnie C Abbruzzese, MS, RD, CCRA (1)  ·  Fred M Baik (1)  ·  Jennifer L Shah (1)

Results publications

PMID 35958955

NIH funding

2018 (1), P30CA124435 (1), R01CA190306 (1)